Sunitinib

Post Date:
Jan 22,2018
Expiry Date:
Jan 22,2019
Detailed Description:
Cas No. :557795-19-4 Quantity: 8Kilograms
Payment Method: 100% T/T in advance
Sunitinib is a cancer medicine that interferes with the growth and spread of cancer cells in the body and used to treat certain types of advanced or progressive tumors of the digestive system, the pancreas, or the kidneys.
CAS Registry Number:
557795-19-4
Synonyms:
;sunitinib base;n-(2-diethylaminoethyl)-5-[(z)-(5-fluoro-2-oxo-indolin-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide;1h-pyrrole-3-carboxamide, n-(2-(diethylamino)ethyl)-5-((z)- (5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl)-2,4- Dimethyl-;n-(2-(diethylamino)ethyl)-5-((z)-(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl)-2,4-dimethyl-1h-pyrrole-3-carboxamide;N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (2Z)-but-2-enedioate;Sulitinib;
Molecular Formula:
C₂₆H₃₁FN₄O₆
Molecular Weight:
514.5459
Molecular Structure:

Offter to Sell